Understanding Postoperative Pleural Empyema in Mesothelioma Patients

ByHolly Zink
Understanding Postoperative Pleural Empyema in Mesothelioma Patients

Pleural mesothelioma, a cancer linked to asbestos exposure, can be challenging to treat. Surgery is a key part of the treatment plan for patients with a chance for a cure. But after surgery, complications can occur.

One such complication is pleural empyema, a serious chest infection. It can affect patient recovery. A recent study looked at the factors that could increase the risk of empyema.

Identifying Risk Factors

The study was at the University Hospital of Zurich. It analyzed data from 400 patients. They had surgery for pleural mesothelioma between September 1999 and February 2023. Of these patients, 12.5% developed postoperative empyema. The analysis revealed something interesting. Patients who had EPP had a much higher risk of getting pleural empyema after surgery. This was compared to those having other surgical procedures.

Understanding the Impact

The impact of postoperative empyema on patient outcomes is profound. It raises death and sickness rates. It also hurts survival. Patients who got empyema had much shorter survival. This was compared to those who did not.

The findings stress the need for careful surgery choices in pleural mesothelioma patients. Recommended options are pleurectomy and decortication, or the more extensive version. These are better than extrapleural pneumonectomy. The study also highlights possible risks from extra radiotherapy. It links this treatment to post-surgery pleural empyema. More research is needed.

Future Directions

Postoperative pleural empyema is a big issue in treating pleural mesothelioma. This is true despite advances in surgery and management. More research is needed on its risk factors and how to assess surgery risks. By spotting changes in clinical and preoperative factors, providers can improve treatment. This helps patient outcomes.

Surgery is key for treating pleural mesothelioma. Yet, the risk of complications like postoperative empyema must be carefully considered. Healthcare providers can care for patients better. They can do this by addressing risk factors and using proven treatments.

Source:

Henschke, Peter, Laura Guglielmetti, Sven Hillinger, Gian-Marco Monsch, Didier Schneiter, Isabelle Opitz, and Olivia Lauk. “Risk Factors Influencing Postoperative Pleural Empyema in Patients with Pleural Mesothelioma: A Retrospective Single-Centre Analysis.” European Journal of Cardio-Thoracic Surgery, April 18, 2024, ezae137. https://doi.org/10.1093/ejcts/ezae137.

 

Similar Posts

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    ByAlex Strauss

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…

  • | |

    Value of Mesothelioma Surgery Challenged for Healthy Patients

    ByAlex Strauss

    New research conducted in Italy and presented at the 15th World Conference on Lung Cancer in Sydney, Australia suggests that mesothelioma surgery – no matter what kind – may not offer a survival advantage over medical management for the healthiest of patients. Mesothelioma is a rare but aggressive malignancy that is highly resistant to standard cancer treatments. The two types of mesothelioma surgery considered to be options for people with resectable cancer are pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP). While EPP is more radical than P/D because it involves removing a lung, both carry a heavy risk of complications and, according to the Italian researchers, may not be of value for certain patients. The study reviewed data from 1,365…

  • | |

    Mesothelioma Surgery May Have Added Benefit

    ByAlex Strauss

    Cancer researchers at Wake Forest University have found another benefit to the cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) combination used to treat peritoneal mesothelioma and other abdominal cancers: the control of fluid buildup. Fluid accumulation in the abdomen because of peritoneal mesothelioma or another type of cancer is known as ascites. Left untreated, ascites can cause bloating, discomfort, disfiguration, and shortness of breath when it interferes with the movement of the diaphragm. While patients with peritoneal mesothelioma, an aggressive cancer of the peritoneal surface, can have this fluid drained off, it often reaccumulates. But the new Wake Forest research suggests that CRS/HIPEC may offer a more permanent solution. Fifteen percent of the cancer patients in the study had…

  • | |

    P/D for Mesothelioma: Are the Studies Accurate?

    ByAlex Strauss

    A new analysis of pleurectomy/decortication suggests that the most radical form of the surgery produces the best results for mesothelioma patients, but also carries the greatest risk. Pleurectomy/decortication or P/D involves the removal of the pleural lining where malignant mesothelioma grows. Removing all or part of the lining frees up the lungs to expand again, relieving life-limited mesothelioma symptoms such as shortness of breath. But, as the Australian researchers found in their mesothelioma analysis, the varying degrees of P/D can make it difficult to accurately compare the method to the more extensive lung-removing surgery or even to get an accurate picture of P/D outcomes. Extended or ‘radical’ P/D involves removing the entire pleural lining, while partial P/D involves removing only part…

  • | |

    Mesothelioma Study Cites Risks & Benefits of Second Surgery

    ByAlex Strauss

    Peritoneal mesothelioma patients who have cytoreductive surgery (CRS) and heated chemotherapy can sometimes benefit from a second surgery, but it may be harder the second time around. Researchers in France have recently published their findings in a study of patients with mesothelioma and other peritoneal cancers who experienced recurrence after  cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Peritoneal mesothelioma is an asbestos-related malignancy that spreads across the peritoneum, the membrane that lines the abdomen. For patients who are healthy enough to undergo it, cytoreductive surgery to remove as much of the cancer as possible, followed by a solution of heated chemotherapy drugs, has been shown to improve survival. But the French team wanted to examine the possible options for people…

  • | |

    Mesothelioma Report Suggests Clinical Trials Better Than Surgery

    ByAlex Strauss

    Doctors in the Department of Respiratory medicine at York Teaching Hospital in the UK are taking a hard stance against the surgical treatment of malignant pleural mesothelioma. In a recent article in the journal Thorax, the group contends that the research surrounding mesothelioma surgery is largely flawed and that the majority of mesothelioma patients would be better served if their doctors suggested alternatives. “Belief that the modest survival times reported after radical surgery, whether alone or as part of multimodal therapy, are longer than they would have been without surgery relies on data from highly selected, uncontrolled, retrospectively analyzed case series,” they write. They point out that the only randomized study, the Mesothelioma and Radical Surgery (MARS) trial showed no measurable…